Alpha Cubed Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.84M Sell
64,947
-186
-0.3% -$17.5K 0.23% 58
2025
Q3
$5.47M Sell
65,133
-1,493
-2% -$123K 0.19% 59
2025
Q2
$5.27M Sell
66,626
-1,636
-2% -$130K 0.2% 60
2025
Q1
$6.13M Sell
68,262
-161,076
-70% -$15M 0.27% 60
2024
Q4
$22.8M Sell
229,338
-2,189
-0.9% -$226K 1.04% 30
2024
Q3
$26.3M Buy
231,527
+7,529
+3% +$894K 1.17% 28
2024
Q2
$27.7M Sell
223,998
-7,617
-3% -$981K 1.32% 24
2024
Q1
$30.6M Sell
231,615
-1,530
-0.7% -$189K 1.6% 22
2023
Q4
$25.4M Sell
233,145
-9,117
-4% -$946K 1.42% 21
2023
Q3
$24.9M Sell
242,262
-12,758
-5% -$1.38M 1.68% 18
2023
Q2
$29.4M Sell
255,020
-17,169
-6% -$1.95M 1.98% 11
2023
Q1
$29M Sell
272,189
-16,400
-6% -$1.77M 2.1% 9
2022
Q4
$32M Sell
288,589
-83,138
-22% -$8.5M 2.42% 5
2022
Q3
$32M Buy
371,727
+16,417
+5% +$1.47M 2.5% 6
2022
Q2
$32.4M Buy
355,310
+15,071
+4% +$1.34M 2.35% 9
2022
Q1
$27.9M Buy
340,239
+43,587
+15% +$3.44M 1.79% 19
2021
Q4
$22.7M Buy
296,652
+4,944
+2% +$394K 1.49% 23
2021
Q3
$21.9M Buy
291,708
+13,948
+5% +$1.06M 1.65% 18
2021
Q2
$21.6M Buy
277,760
+1,097
+0.4% +$81.6K 1.56% 21
2021
Q1
$20.4M Buy
276,663
+24,764
+10% +$1.83M 1.58% 20
2020
Q4
$19.7M Buy
251,899
+52,491
+26% +$4.01M 1.68% 17
2020
Q3
$15.8M Buy
199,408
+13,944
+8% +$1.09M 1.51% 22
2020
Q2
$13.7M Sell
185,464
-610
-0.3% -$45.9K 1.5% 24
2020
Q1
$13.7M Buy
186,074
+112,738
+154% +$8.86M 1.64% 22
2019
Q4
$6.36M Buy
73,336
+265
+0.4% +$21.8K 0.65% 43
2019
Q3
$5.87M Buy
73,071
+235
+0.3% +$18.8K 0.68% 37
2019
Q2
$5.83M Buy
72,836
+59,905
+463% +$4.59M 0.67% 41
2019
Q1
$1.03M Buy
12,931
+1,603
+14% +$120K 0.12% 94
2018
Q4
$826K Sell
11,328
-3,240
-22% -$229K 0.12% 91
2018
Q3
$1.01M Buy
14,568
+4,960
+52% +$316K 0.12% 110
2018
Q2
$556K Buy
9,608
+207
+2% +$11.7K 0.07% 114
2018
Q1
$489K Buy
9,401
+930
+11% +$50.2K 0.06% 128
2017
Q4
$455K Sell
8,471
-741
-8% -$41.1K 0.06% 147
2017
Q3
$563K Buy
9,212
+212
+2% +$12.9K 0.08% 122
2017
Q2
$550K Buy
9,000
+626
+7% +$38.1K 0.09% 105
2017
Q1
$508K Buy
8,374
+1,961
+31% +$119K 0.1% 105
2016
Q4
$360K Sell
6,413
-1,112
-15% -$65.1K 0.09% 135
2016
Q3
$448K Buy
+7,525
New +$440K 0.12% 103
2016
Q2
Sell
-7,114
Closed -$359K 160
2016
Q1
$359K Sell
7,114
-103,516
-94% -$5.07M 0.11% 111
2015
Q4
$5.58M Sell
110,630
-9,393
-8% -$474K 1.46% 19
2015
Q3
$6.26M Buy
120,023
+15,295
+15% +$812K 1.64% 14
2015
Q2
$5.69M Buy
104,728
+22,962
+28% +$1.29M 1.53% 15
2015
Q1
$4.49M Buy
+81,766
New +$4.63M 1.4% 23
2014
Q1
Sell
-18,558
Closed -$886K 189
2013
Q4
$886K Buy
+18,558
New +$848K 0.32% 102

Other funds holding MRK

Alpha Cubed Investments's MRK Position: Q4 2025 in Review

Alpha Cubed Investments reduced its Merck (MRK) stake by 0.29% in Q4 2025, selling an estimated $17.5K and leaving 64,947 shares worth $6.84M. The position accounts for 0.23% of the portfolio, ranked #58.

Alpha Cubed Investments first reported a position in MRK in Q4 2013 and has held it in 44 quarters since. The position peaked at $32.4M in Q2 2022. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Alpha Cubed Investments held 64,947 shares of Merck worth $6.84M as of Q4 2025.
  • Alpha Cubed Investments sold 186 Merck shares in Q4 2025, an estimated $17.5K.
  • Merck made up 0.23% of Alpha Cubed Investments's portfolio in Q4 2025, its #58 holding.
  • Alpha Cubed Investments first reported a position in Merck in Q4 2013 and has held it in 44 quarters since.
  • Alpha Cubed Investments's Merck position peaked at $32.4M in Q2 2022.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Alpha Cubed Investments's 13F filing for Q4 2025, filed 3 Feb 2026.